Reports of European investigations into Oxford University/AstraZeneca vaccine

March 17, 2021 | News, COVID-19

A small number of European countries have paused their rollout of the AstraZeneca COVID-19 vaccine due to a small number (37) of instances of blood clots in people who have received this vaccine. These countries have stated that they are doing so out of an “abundance of caution.” The World Health Organization, Health Canada and the European Medicines Agency have been clear that there is no evidence that these instances were caused by the vaccine. Blood clots usually happen at this frequency—or higher—in the general population.

Additionally, the AstraZeneca vaccine being used in BC is manufactured in the USA and is not the same “lot” as the vaccine being used in Europe, where these incidents have taken place.

Watch Dr Bonnie Henry give more detail here.